US Patent 9045435 Quinazoline compounds as sodium channel blockers
Patent 9045435 was granted and assigned to Purdue Pharma on June, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9045435 Quinazoline compounds as sodium channel blockers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.